Insider Transactions in Q4 2021 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2021
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
85,279
-10.44%
|
$1,705,580
$20.11 P/Share
|
|
Nov 23
2021
|
Donald Steven Furman Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
100,000
-5.18%
|
$2,000,000
$20.11 P/Share
|
|
Nov 23
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
419,646
-10.53%
|
$8,392,920
$20.11 P/Share
|
|
Nov 23
2021
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
83,367
-7.79%
|
$1,667,340
$20.11 P/Share
|
|
Nov 23
2021
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
127,843
-7.79%
|
$2,556,860
$20.11 P/Share
|
|
Nov 23
2021
|
Mark B. Mc Clellan Director |
SELL
Open market or private sale
|
Direct |
7,500
-2.64%
|
$150,000
$20.11 P/Share
|
|
Nov 23
2021
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,033,936
-8.2%
|
$40,678,720
$20.11 P/Share
|
|
Nov 23
2021
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
6,259,298
-8.2%
|
$125,185,960
$20.11 P/Share
|
|
Nov 23
2021
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
6,259,298
-8.2%
|
$125,185,960
$20.11 P/Share
|
|
Nov 23
2021
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,033,936
-8.2%
|
$40,678,720
$20.11 P/Share
|
|
Nov 02
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
29,302
-0.73%
|
$556,738
$19.93 P/Share
|
|
Nov 01
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
70,698
-1.73%
|
$1,343,262
$19.91 P/Share
|
|
Nov 01
2021
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.93%
|
$190,000
$19.87 P/Share
|
|
Nov 01
2021
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.28%
|
$22,800
$19.82 P/Share
|
|
Oct 20
2021
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
23,000
-2.74%
|
$437,000
$19.38 P/Share
|
|
Oct 14
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,097
-1.04%
|
$775,746
$18.83 P/Share
|
|
Oct 13
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,262
-0.03%
|
$23,978
$19.0 P/Share
|
|
Oct 13
2021
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
155,641
-3.63%
|
$2,801,538
$18.44 P/Share
|
|
Oct 13
2021
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.92%
|
$180,000
$18.08 P/Share
|
|
Oct 13
2021
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.28%
|
$21,600
$18.0 P/Share
|